Hi-Tech Pharmacal Co., Inc. HITK announced today the signing of a definitive agreement under which Hi-Tech acquired exclusive rights to the Cormax brand from Watson Laboratories for an undisclosed sum of money. Cormax, a branded version of clobetasol propionate topical solution 0.05%, is indicated for the treatment dermatoses of the scalp.
The Cormax® brand will be sold through the Company's branded prescription subsidiary, ECR Pharmaceuticals. ECR will launch Cormax® in June 2012. The brand had sales of approximately $600,000 in 2011 according to IMS data.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in